Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICU observational study of delayed residual neuromuscular blockade and rocuronium-sugammadex pharmacokinetics after gastrointestinal surgery
jRCT1030260606Not yet recruiting
- Sponsor
- Department of Anesthesiology, Nihon University School of Medicine
- Start
- Oct 2026
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of rocuronium and Sugammadex in neuromuscular block (NMB), sponsored by Department of Anesthesiology, Nihon University School of Medicine. Primary endpoint: Exposure-response relationship and redistribution parameters. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
rocuroniumSugammadex
03
Conditions
neuromuscular block (NMB)
Beyond the preview
Go deeper on jRCT1030260606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030260606.